Abstract
The International Scientific Research Organization for Science, Engineering and Technology (ISROSET) is a Non-Profit Organization; The ISROSET is dedicated to improvement in academic sectors of Science (Chemistry, Bio-chemistry, Zoology, Botany, Biotechnology, Pharmaceutical Science, Bioscience, Bioinformatics, Biometrics, Biostatistics, Microbiology, Environmental Management, Medical Science, Forensic Science, Home Science, Library Science, Material Science Military Science, Physical Science, Physical Education Science, Educational Science, Fisheries, seed technology, Agriculture, Forestry Science, Mathematics, Physics, Statistics and Geology/Earth Science), Computer Science, Engineering and Information Technology, Commerce, Management, Economics Sociology and Social Science.
Highlights
As per the WHO (World Health Organization 2011) report, rather than coronary heart disease or stroke, cancer causes more deaths worldwide and over 20 million new cancer cases is expected by 2025 [1]
Preoperative blood samples were collected from the newly diagnosed breast cancer patients and complete blood profiling was performed with an aim to evaluate the relative percentage and ratio of Neutrophil, Monocytes, Lymphocyte and Platelets and the obtained results were compared with other clinic-pathological and socio-demographic data of the to rule out overall health status of the breast cancer patients
Total 100 newly diagnosed and histologically confirmed Breast Cancer patients were undergone primary preoperative screening, out of which the 71 patients were included in this study and remaining 29 were excluded based on exclusion criterion
Summary
As per the WHO (World Health Organization 2011) report, rather than coronary heart disease or stroke, cancer causes more deaths worldwide and over 20 million new cancer cases is expected by 2025 [1]. Cancer is a major public health challenge in India too and recent data from ICMR (Indian Council of Medical Research) estimated that there are nearly 1.5 lakh new breast cancer cases reported during 2016. Established prognostic and predictive markers for breast cancer are age, tumour size, grade, nodal status, and endocrine/Her2neu receptor status [4]. TNM (Tumor, Nodes, and Metastasis) staging and lymph node status is considered the most important and widely used prognostic marker, the overall behavior of breast cancers is unpredictable with significantly different clinical outcomes of the treatments from patients with the same lymph node status and staging [5]. Type of Treatment undertaken by Confirmed Breast Cancer Patients Surgery Chemotherapy
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Scientific Research in Biological Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
